Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients

Wiener Klinische Wochenschrift

Volumn 126, Issue 7-8, 2014, Pages 195-200

  Strehblow, Christoph ^a   Smeikal, Michael ^a   Fasching, Peter ^a  

^a WILHELMINEN HOSPITAL   (Austria)

Author keywords

Comorbidity; Drug therapy; Hospitalization; Octogenarians; Polypharmacy

Indexed keywords

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC LUNG DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONNECTIVE TISSUE DISEASE; DEMENTIA; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PERIPHERAL VASCULAR DISEASE; POLYPHARMACY; SOLID TUMOR; VERY ELDERLY; ACUTE DISEASE; AGE DISTRIBUTION; AUSTRIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DRUG USE; INAPPROPRIATE PRESCRIBING; INCIDENCE; LENGTH OF STAY; LUNG DISEASES; PRESCRIPTION; RISK FACTOR; SEX RATIO; STATISTICS AND NUMERICAL DATA;

ACUTE DISEASE; AGE DISTRIBUTION; AGED, 80 AND OVER; AUSTRIA; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; COMORBIDITY; DIABETES MELLITUS; DRUG PRESCRIPTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; INCIDENCE; LENGTH OF STAY; LUNG DISEASES; MALE; POLYPHARMACY; RISK FACTORS; SEX DISTRIBUTION;

EID: 84901278597     PISSN: 00435325     EISSN: 16137671     Source Type: Journal    
DOI: 10.1007/s00508-013-0485-1     Document Type: Article

References (32)

1. Linjakumpu T, Hartikainen S, Klaukka T, et al. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002 Aug;55(8):809-17.
2. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5:345-51.
3. Tinetti ME, Bogardus ST, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870-4.
4. Zulman DM, Sussman JB, Chen X, et al. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011 Jul;26(7):783-90.
5. Cherubini A, Oristrell J, Pla X, et al. The persistent exclusion of older patients from ongoing clinical trials regarding heart failure. Arch Intern Med. 2011 Mar 28;171(6):550-6.
6. Grabowski DC, Ellis JE. High body mass index does not predict mortality in older people: analysis of the Longitudinal Study of Aging. J Am Geriatr Soc. 2001;49:968-79. (Pubitemid 32743634)
7. Oreopoulos A, Padwal R, Kalantar-Zadeh K, et al. Body mass index and mortality in heart failure: a meta-analysis. Am Heart J. 2008;156:1322.
8. Gussekloo J, van Exel E, de Craen AJ, et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004 Dec 1;292(21):2591-9. (Pubitemid 39577515)
9. Rosholm JU, Christensen K. Relationship between drug use and self-reported health in elderly Danes. Eur J Clin Pharmacol. 1997;53:179-83. (Pubitemid 28018288)
10. Haider SI, Johnell K, Thorslund M, et al. Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or = 77 years in Sweden. Clin Ther. 2008;30:419-27. (Pubitemid 351474380)
11. Junius-Walker U, Theile G, Hummers-Pradier E. Prevalence and predictors of polypharmacy among older primary care patients in Germany. Fam Pract. 2007;24:14-9. (Pubitemid 46454660)
12. Bjerrum L, Søgaard J, Hallas J, et al. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study. Eur J Clin Pharmacol. 1998;54:197-202. (Pubitemid 28288289)
13. Mansur N, Weiss A, Hoffman A, et al. Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging. 2008;25:861-70.
14. Barat I, Andreasen F, Damsgaard EM. Drug therapy in the elderly: what doctors believe and patients actually do. Br J Clin Pharmacol. 2001;51:615-22. (Pubitemid 32862751)
15. Thiruchselvam T, Naglie G, Moineddin R, et al. Risk factors for medication nonadherence in older adults with cognitive impairment who live alone. Int J Geriatr Psychiatry. 2012 Dec;27(12):1275-82.
16. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatr Soc. 2012;60;34-41.
17. Ziere G, Dieleman JP, Hofman A, et al. Polypharmacy and falls in the middle age and elderly population. Br J Clin Pharmacol. 2006;61:218-23. (Pubitemid 43382615)
18. Kuijpers MA, van Marum RJ, Egberts AC, et al. OLDY (OLd people Drugs & dYsregulations) Study Group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65:130-3.
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-83. (Pubitemid 17055592)
20. Jensen GL, Friedmann JM, Coleman CD, et al. Screening for hospitalization and nutritional risks among community-dwelling older persons. Am J Clin Nutr. 2001;74:201-5. (Pubitemid 32702486)
21. Veehof LJ, Stewart RE, Meyboom-de Jong B, et al. Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol. 1999;55:533-6. (Pubitemid 29446555)
22. Nobili A, Licata G, Salerno F, et al. Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. Eur J Clin Pharmacol. 2011;67(5):507-19.
23. Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012 Sep;65(9):989-95.
24. Mizokami F, Koide Y, Noro T, et al. Polypharmacy with common diseases in hospitalized elderly patients. Am J Geriatr Pharmacother. 2012;10:123-8.
25. Jyrkkä J, Enlund H, Korhonen MJ, et al. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75 + study: a cross-sectional analysis. Drugs Aging. 2009;26:493-503.
26. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes. Eur J Clin Pharmacol. 2000;56:501-9.
27. Onder G, Liperoti R, Fialova D, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67:698-704.
28. Eggen AE. Pattern of drug use in a general population - prevalence and predicting factors: the Tromsø study. Int J Epidemiol. 1994;23:1262-72.
29. Corsonello A, Antonelli Incalzi R, Pistelli R, et al. Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2011;17 Suppl 1:21-8.
30. Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362(9386):777-81. (Pubitemid 37093918)
31. Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med. 2008;359(23):2456-67.
32. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-847.